175 related articles for article (PubMed ID: 34900089)
1. Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress.
Guo J; Qin Z; He Q; Fong TL; Lau NC; Cho WCS; Zhang H; Meng P; Xing X; Li M; Zhang ZJ; Chen H
Oxid Med Cell Longev; 2021; 2021():7644648. PubMed ID: 34900089
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial.
Yang Y; Gao S; Fang Q; Zhu M
Medicine (Baltimore); 2021 Jan; 100(3):e24246. PubMed ID: 33546045
[TBL] [Abstract][Full Text] [Related]
3. [Huoxue anxin recipe alleviated peroxidation damage of acute myocardial infarction rats by regulating iNOS/eNOS imbalance: an experimental research].
Zhang Y; Wang J; Guo LL; Wu GJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1356-60. PubMed ID: 24432679
[TBL] [Abstract][Full Text] [Related]
4. Exploring the mechanism underlying the cardioprotective effect of shexiang baoxin pill on acute myocardial infarction rats by comprehensive metabolomics.
Wu G; Chen L; Gu Y; Hong Y; Ma J; Zheng N; Zhong J; Liu AJ; Sheng L; Zhang W; Li H
J Ethnopharmacol; 2020 Sep; 259():113001. PubMed ID: 32464316
[TBL] [Abstract][Full Text] [Related]
5. Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction.
Song N; Lu D; Wu G; Wang S; Zeng Y; Zhao J; Meng Q; He H; Chen L; Zhu H; Liu A; Li H; Shen X; Zhang W; Zhou H
J Ethnopharmacol; 2022 Jul; 293():115279. PubMed ID: 35405256
[TBL] [Abstract][Full Text] [Related]
6. Kaempferide-7-O-(4"-O-acetylrhamnosyl)-3-O-rutinoside reduces myocardial infarction size after coronary artery ligation in rats.
Eerduna G; Wei D; Yu X; Qu S; Sui D
Pharmazie; 2013 Jun; 68(6):453-8. PubMed ID: 23875254
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients.
Ali F; Naqvi SA; Bismillah M; Wajid N
Indian Heart J; 2016; 68(3):325-31. PubMed ID: 27316485
[TBL] [Abstract][Full Text] [Related]
8. Study of the mechanism of Shexiang Baoxin pill-mediated angiogenesis in acute myocardial infarction.
Wei J; Dong B; Du X; Xu H
Cardiovasc J Afr; 2023 Jul; 34():1-7. PubMed ID: 37526966
[TBL] [Abstract][Full Text] [Related]
9. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
[TBL] [Abstract][Full Text] [Related]
10. Antioxidation Role of Different Lateral Stellate Ganglion Block in Isoproterenol-Induced Acute Myocardial Ischemia in Rats.
Wei N; Chi M; Deng L; Wang G
Reg Anesth Pain Med; 2017; 42(5):588-599. PubMed ID: 28820802
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics reveals Shexiang Baoxin Pill exerts cardioprotective effects by preserving energy metabolism in a rat model of myocardial infarction.
Yu F; Yu Y; Tian S; Zhou Y; Chen X; Ye J; Liu Q; Xu X; Zhou H; Zhang W
J Ethnopharmacol; 2021 Feb; 266():113460. PubMed ID: 33039626
[TBL] [Abstract][Full Text] [Related]
12. [Effect of fulu baoxin oral liquid on lipid peroxidation, plasma nitric oxide and vascular endothelial growth factor in acute myocardial infarction rats].
Huang J; Huang YS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):926-9. PubMed ID: 17121047
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial.
Tian PP; Li J; Gao J; Li Y
BMJ Open; 2018 Feb; 8(2):e018052. PubMed ID: 29444778
[TBL] [Abstract][Full Text] [Related]
14. A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review.
Zhou Z; Shen W; Yu L; Xu C; Wu Q
J Ethnopharmacol; 2016 Dec; 194():1130-1139. PubMed ID: 27847338
[TBL] [Abstract][Full Text] [Related]
15. Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
Huang F; Liu Y; Yang X; Che D; Qiu K; Hammock BD; Wang J; Wang MH; Chen J; Huang H
Atherosclerosis; 2017 Aug; 263():184-191. PubMed ID: 28646793
[TBL] [Abstract][Full Text] [Related]
16. Danlou Fang reduces microvascular obstruction through the endothelial/inducible nitric oxide synthase pathway in a rat model.
Dai X; Chen R; Chen T; Yan H; Wang Y; Zhou K; Zhang X; Wang Y
J Tradit Chin Med; 2021 Apr; 41(2):246-253. PubMed ID: 33825404
[TBL] [Abstract][Full Text] [Related]
17. Shenyuan, an extract of American Ginseng and Corydalis Tuber formula, attenuates cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and oxidative stress in a porcine model of acute myocardial infarction.
Zhu XY; Zhang ZL; Li P; Liang WY; Feng XR; Liu ML
J Ethnopharmacol; 2013 Nov; 150(2):672-81. PubMed ID: 24096202
[TBL] [Abstract][Full Text] [Related]
18. Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease.
Wu G; Liao J; Zhu X; Zhang Y; Lin Y; Zeng Y; Zhao J; Zhang J; Yao T; Shen X; Li H; Hu L; Zhang W
Phytomedicine; 2024 Jul; 130():155727. PubMed ID: 38781732
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
Wei J; Liu S; Wang X; Li B; Qiao L; Wang Y; Zhu M
Evid Based Complement Alternat Med; 2021; 2021():2672516. PubMed ID: 34931125
[TBL] [Abstract][Full Text] [Related]
20. [Promotion of Function of Endothelial Progenitor Cells with Shexiang Baoxin Pill Treatment under Shear Stress].
Li G; Chen Y; Wu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):847-53. PubMed ID: 26710458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
